Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Harrison

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
BMJ Global Health|April 9, 2025
Epidemiology of sepsis in hospitalised neonates in Indonesia: high burden of multidrug-resistant infections reveals poor coverage provided by recommended antibiotic regimensNina Dwi Putri, Benjamin Fr Dickson, Riyadi Adrizain, et al.
JCO Clinical Cancer Informatics|February 22, 2020
CART-WHEEL.org: An Ethically Approved Online Database for Patient-Entered Data to Facilitate Rare Cancer ResearchDamien Kee, Clare Parker, Susie Bae, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|February 1, 2024
Mucinous ovarian carcinoma: A survey of practice in Australia and New ZealandNiveditha Rajadevan, Ariane Flinkier, Hugo Saunders, et al.
JACC. Heart Failure|August 12, 2019
Decline in Left Ventricular Ejection Fraction Following Anthracyclines Predicts Trastuzumab CardiotoxicityShom Goel, Jia Liu, Hao Guo, et al.
Drug Design, Development and Therapy|April 8, 2020
A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in AustraliaJason D Lickliter, Hui K Gan, Mark Voskoboynik, et al.
JAMA Network Open|August 9, 2024
Validity of Patient-Reported Outcome Measures in Evaluating Nerve Damage Following ChemotherapyTiffany Li, Hannah C Timmins, Fawaz M Mahfouz, et al.
BJU International|November 21, 2023
A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinomaCiara Conduit, Ian D Davis, Jeffrey C Goh, et al.
Scientific Reports|January 26, 2018
Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancerBo Gao, Yi Lu, Annemieke J M Nieuweboer, et al.
The Lancet Regional Health. Western Pacific|September 25, 2025
Pathogen distribution and antimicrobial resistance among neonatal bloodstream infections in Southeast Asia: results from NeoSEAP, a multicentre retrospective studyBenjamin F R Dickson, Michelle Harrison, Maria Esterlita T Villanueva-Uy, et al.
Cell Reports|September 24, 2013
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenograftsShunqiang Li, Dong Shen, Jieya Shao, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
BMJ Global Health|April 9, 2025
Epidemiology of sepsis in hospitalised neonates in Indonesia: high burden of multidrug-resistant infections reveals poor coverage provided by recommended antibiotic regimensNina Dwi Putri, Benjamin Fr Dickson, Riyadi Adrizain, et al.
JCO Clinical Cancer Informatics|February 22, 2020
CART-WHEEL.org: An Ethically Approved Online Database for Patient-Entered Data to Facilitate Rare Cancer ResearchDamien Kee, Clare Parker, Susie Bae, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|February 1, 2024
Mucinous ovarian carcinoma: A survey of practice in Australia and New ZealandNiveditha Rajadevan, Ariane Flinkier, Hugo Saunders, et al.
JACC. Heart Failure|August 12, 2019
Decline in Left Ventricular Ejection Fraction Following Anthracyclines Predicts Trastuzumab CardiotoxicityShom Goel, Jia Liu, Hao Guo, et al.
Drug Design, Development and Therapy|April 8, 2020
A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in AustraliaJason D Lickliter, Hui K Gan, Mark Voskoboynik, et al.
JAMA Network Open|August 9, 2024
Validity of Patient-Reported Outcome Measures in Evaluating Nerve Damage Following ChemotherapyTiffany Li, Hannah C Timmins, Fawaz M Mahfouz, et al.
BJU International|November 21, 2023
A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinomaCiara Conduit, Ian D Davis, Jeffrey C Goh, et al.
Scientific Reports|January 26, 2018
Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancerBo Gao, Yi Lu, Annemieke J M Nieuweboer, et al.
The Lancet Regional Health. Western Pacific|September 25, 2025
Pathogen distribution and antimicrobial resistance among neonatal bloodstream infections in Southeast Asia: results from NeoSEAP, a multicentre retrospective studyBenjamin F R Dickson, Michelle Harrison, Maria Esterlita T Villanueva-Uy, et al.
Cell Reports|September 24, 2013
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenograftsShunqiang Li, Dong Shen, Jieya Shao, et al.
Pageof 8